Publications
Publications
  • November 2013
  • Case
  • HBS Case Collection

GlaxoSmithKline in China (A)

By: John A. Quelch and Margaret L. Rodriguez
  • Format:Print
  • | Language:English
ShareBar

Abstract

Four GlaxoSmithKline employees were accused of bribing Chinese health care workers to prescribe the company's drugs. The accusations brought to light the questionable incentive structures of the Chinese health care system and the pressure on companies to adhere to local customs while still observing local laws.

Keywords

Public Health; Pharmaceuticals; China; Bribery; CSR; Hong Bao; Health Care; Drug; GlaxoSmithKline; GSK; Witty; Government; Marketing; Health; Health Care and Treatment; Corporate Social Responsibility and Impact; Corporate Strategy; Corporate Governance; Business and Government Relations; Ethics; Pharmaceutical Industry; China; United Kingdom; United States

Citation

Quelch, John A., and Margaret L. Rodriguez. "GlaxoSmithKline in China (A)." Harvard Business School Case 514-049, November 2013.

About The Author

John A. Quelch

More Publications

Related Work